Week |
Course Content |
Week 1 |
實驗動物替代方案簡介
Introduction to 3R alternatives
|
Week 2 |
3R模式在動物用藥品檢驗與法規修正中的應用評估
Application of 3R models in the regulation of animal drug
|
Week 3 |
腸道類器官替代系統用於抗病毒藥物篩選平台的建立
Establishment of intestinal organoid system for antiviral methods evaluation
|
Week 4 |
替代方案新科技–器官晶片之開發與解密
Organ-on-a-chip
|
Week 5 |
替代性試驗模式在化妝品開發中的應用與現況
Alternatives in cosmetics industries
|
Week 6 |
臺灣生技產業中的毒性試驗替代方案總覽
Overview of toxicity trials with alternative systems in Taiwan
|
Week 7 |
以呼吸道3D組織培養系統替代傳統動物試驗的歐洲案例分享
European experience on using airway 3D cultures to replace animal experiments.
|
Week 8 |
法規內急毒性(6-pack)替代試驗及策略(OECD TG、IATA、DA)的應用
Application of acute toxicity (6-pack) alternatives and strategies (OECD TG, IATA, DA)
|
Week 9 |
Midterm Examination |
Week 10 |
初代細胞培養技術在替代動物實驗中的應用與誤區
Pros and cons of using primary animal culture systems for replacing animal models
|
Week 11 |
人類和動物疾病體外 (in vitro) 模式與動物試驗之可擬性評估
Comparison between in vitro models and in vivo animal trials
|
Week 12 |
讓愛延續–利用已亡故動物之生物樣材發展實驗動物替代試驗模型
Using specimen from animal corpse for developing 3R alternative systems
|
Week 13 |
實驗動物零使用–新式動物疫苗生產與評估
No more lab animals – Evaluation of cell-based vaccines and their usage
|
Week 14 |
電腦模擬分析與毒性預測評估人工智慧演算平台
In silico platform development: Toxicity prediction based on artificial intelligence
|
Week 15 |
實驗動物減量方程式:離體系統和活體器官切片的應用
One is more – ex vivo models and precision-cut tissue slices
|
Week 16 |
動物用一般藥品生體可用率及生體相等性試驗基準及溶離試驗替代方案
Bioequivalence alternative standards for animal pharmaceutical products
|
Week 17 |
疫苗開發動物試驗減量及替代方案應用之產業實例
Industrial examples of animal testing reduction and alternative solutions in vaccine development
|
Week 18 |
Examination |